FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to chemical-pharmaceutical industry. Created injection solution possesses chemical stability and intensified nootropic activity in comparison with phenotrophyl pills. Solution is prepared by dissolving phenotrophyl and 2-hydroxipropyl-β-cyclodextrine in water for injections with following filtering, preferably through filter with pore size not more than - 0.3 mcm and following thermal sterilisation.
EFFECT: obtaining pharmaceutical composition, which has nootropic activity, made in form of solution for injections, which contains phenotropyl.
2 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
| MEDICATION POSSESSING ANTIDEPRESSIVE, ANXIOLYTIC AND NOOTROPIC ACTION | 2010 |
|
RU2437659C1 |
| QUINAZOLINE DERIVATIVES, POSSESSING ANTIDEPRESSANT, ANXIOLYTIC AND NOOTROPIC ACTIVITY | 2012 |
|
RU2507199C1 |
| DERIVATIVE OF 3-HYDROXYPYRIDINE WITH ANXIOLYTIC AND NOOTROPIC EFFECT | 2017 |
|
RU2664453C1 |
| ANTIDEPRESSANT, ANXIOLYTIC, NEUROPROTECTIVE AND IMMUNOSTIMULATING AGENT | 2010 |
|
RU2429834C1 |
| APPLICATION OF 1-HETARYL-2-NITRO-2-(3-PHENYL-1,2,4-OXADIAZOLE-5-YL)ETHANES AS PSYCHOTROPIC SUBSTANCES | 2009 |
|
RU2420521C1 |
| 4-PHENYL PYRROLIDINONE-2 DERIVATIVE, NOOTROPIC COMPOSITION THEREOF, METHOD FOR PRODUCING THEREOF AND METHOD PREVENTIVE TREATMENT OF NERVOUS SYSTEM DISORDERS | 2015 |
|
RU2611623C2 |
| COMPOUNDS HAVING ANTI-ISCHEMIC, ANTIANGINAL, CYTOPROTECTIVE PROPERTIES, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF, A METHOD OF TREATING A NEURODEGENERATIVE DISEASE, A METHOD OF TREATING A PSYCHIC DISORDER | 2019 |
|
RU2741910C2 |
| (2S,4S)-4-AMINO-N-(4-FLUOROPHENYL)PYROGLUTAMIC ACID EXHIBITING CEREBROPROTECTIVE, NOOTROPIC, AND ANTITHROMBOTIC ACTION | 2021 |
|
RU2769521C1 |
| ANTIDEPRESSANT FOR CORRECTION OF SIDE EFFECTS FROM NEUROLEPTICS | 2019 |
|
RU2746012C2 |
